Position in COGT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$100,973,753
+$7,457,336 QoQ
Shares Held
2,609,141
+7.4% QoQ
Ownership
1.50%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#17
of 321 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 0%
Shared 96%
None 4%
Common Shares in COGT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Invesco Ltd. holds $14,221,834,024 across 296 Biotechnology names. COGT ranks #24 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,043,052 | $3,995,225,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,940,665 | $2,457,162,245 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,754,318 | $1,130,162,341 | |
| 4 | INCY |
Incyte Corp
|
4,080,461 | $462,561,050 | |
| 5 | ARGX |
Argenx SE
|
443,990 | $411,920,598 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
1,671,684 | $409,178,086 | |
| 7 | MRNA |
Moderna, Inc.
|
5,780,299 | $404,794,337 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
1,201,644 | $379,827,645 |
All Filings in COGT
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $100,973,753 | 2,609,141 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $93,516,417 | 2,429,629 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $20,806,371 | 585,765 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $5,345,795 | 372,270 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $811,769 | 113,060 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $411,769 | 68,743 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $301,399 | 38,641 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $5,336,041 | 494,078 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,382,231 | 163,966 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $247,577 | 36,842 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $204,271 | 34,740 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $318,571 | 32,674 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $370,721 | 31,311 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $297,954 | 27,614 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $203,627 | 17,615 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $6,825,645 | 457,483 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $8,060,198 | 893,592 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $91,811 | 12,258 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $101,235 | 11,799 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $102,055 | 12,135 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $5,919,050 | 729,846 | Shares | Defined | 2021-08-17 | |
| 2021-03-31 | $6,173,077 | 703,084 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $7,861,000 | 700,000 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||